Lung Cancer Clinical Trials

Showing 241-260 of 2,032 trials

RECRUITINGPHASE3

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

NCT07189455

The main objective is to compare ZG006 with Investigator-Selected Chemotherapy on prolonging overall survival (OS).

Small-cell Lung Cancer

Suzhou Zelgen Biopharmaceuticals Co.,Ltd420 participantsStarted Dec 2025

Shanghai, Shanghai Municipality, China

COMPLETED

CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer

NCT07316309

This prospective observational study aims to evaluate the clinical value of CXCR4-targeted PET/CT imaging in patients with limited-stage small cell lung cancer (LS-SCLC). Patients diagnosed with LS-SCLC at Shandong Cancer Hospital and Institute underwent \[18F\]AlF-NOTA-QHY-04 PET/CT imaging before receiving standard concurrent chemoradiotherapy. Imaging findings were analyzed and correlated with clinical outcomes, including progression-free survival, to explore the potential role of CXCR4 PET/CT as a prognostic imaging biomarker. The results of this study may help improve risk stratification and outcome prediction in patients with limited-stage small cell lung cancer.

Small Cell Lung Cancer

Shandong Cancer Hospital and Institute33 participantsStarted Nov 2022

Jinan, Shandong, China

RECRUITING

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

NCT00991094

This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the risk of side effects for future patients and learn the long-term benefit of proton therapy.

Breast CarcinomaEsophageal CarcinomaGenitourinary System Carcinoma+6 more

M.D. Anderson Cancer Center5,000 participantsStarted May 2005

Houston, Texas, United States

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Related Searches

Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients

Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)

The HER Project: HRD in EGFR-mutated NSCLC

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer

Molecular Analysis of Thoracic Malignancies

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

SP Thoracic IDE Study

Study Assessing QBS72S For Treating Brain Metastases

A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer

Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer